Emtricitabine/tenofovir disoproxil

DRUG2 trials

Sponsors

University of North Carolina, Chapel Hill, Plan Nacional sobre el Sida (PNS)

Conditions

Coronavirus InfectionHIV Infection

Phase 3

Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel

CompletedNCT04334928

Plan Nacional sobre el Sida (PNS)Coronavirus Infection

Start: 2020-04-15End: 2021-07-11Updated: 2021-09-16

Unknown Phase

Factors Affecting PrEP Adherence

CompletedNCT02411630

University of North Carolina, Chapel HillHIV Infection

Start: 2013-06-30End: 2015-06-30Updated: 2017-02-28

Related Papers

Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial.

2021-11-066 citations

Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial.

2021-06-2747 citations